SONIRE Therapeutics Inc.
PrivateLast Round
Grant
Jun 17, 2026
Est. Valuation
$36.2M
Total Funding Raised
$52.84M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
SONIRE Therapeutics Inc. is a clinical-stage medical device company that develops next-generation ultrasound-guided high-intensity focused ultrasound (HIFU) therapy systems for the non-invasive treatment of solid tumors, with an initial focus on pancreatic cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SONIRE Therapeutics Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
SONIRE Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 17, 2026 | ||||
| Series A | Apr 15, 2026 | ||||
| Series B | Nov 30, 2022 | ||||
| Series A | Jun 11, 2021 |
Key People
Founding team and executive leadership
SONIRE Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| QR Investment Co., Ltd. | Series B |
| スパークル株式会社 | Series A |
| Higin Capital | Series B |
| New Energy and Industrial Technology Development Organization | Grant |
| Japan Growth Capital | Series B |
| Nissay Capital | Series B |
| Daiwa Corporate Investment Co., Ltd. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Raised Series A to advance non-invasive tumor ablation system.
- Apr 15, 2026
Expanded corporate footprint by establishing a new headquarters in Palo Alto, California.
SONIRE Therapeutics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SONIRE Therapeutics Inc.'s valuation, stock price, and market status.